UK Marketing Authorisation Holders urged to register with SecurMed UK
Thanks to the Welsh Government’s £80 million New Treatment Fund, patients are benefiting from collaborative efforts to improve access to the very latest medicines, no matter where they live or what their disease.
The better you understand what’s heading your way, the better you can prepare and plan for the future. Identifying and planning for the availability of new innovative medicines and treatments in the pharmaceutical pipeline is no different.
As the Trade Association which represents the pharmaceutical companies who develop new innovative medicines, the ABPI strongly welcomes the announcement today of a New Treatment Fund in Wales by Vaughan Gething AM, Cabinet Secretary for Health Well-being and Sport.
The Falsified Medicines Directive (FMD) and associated Delegated Regulation introduces measures which aim to prevent the entry of falsified medicines into the legal pharmaceutical supply chain by enabling the verification and authentication of medicines as they move through the supply chain to...
Rick Greville shares an update on the survey commisioned to find out the views of Welsh oncologists and haemato-oncologists’ on access to new cancer treatments in Wales:
Our Director for Wales, Rick Greville talks about how ABPI Cymru Wales has been contributing to the assessment of the Welsh public’s opinion on healthcare delivery, and the how the discovery and access to innovative medicines impacts on patients’ lives.
We are delighted to offer you the opportunity to learn more about how the appraisal process works in Wales, providing a networking opportunity with colleagues from the All Wales Medicines Strategy Group (AWMSG) and the All Wales Therapeutics and Toxicology Centre (AWTTC).
Today, the ABPI updated its guidance on guidelines for collection of adverse events. Why is this important and what difference will it make for you?
We are delighted to give you the opportunity to learn more about the way the Healthcare Technology Appraisal (HTA) process is changing in Wales at this Masterclass on Monday 8 October 2012.